BioSpace News Archive

Genetown

Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences

Inozyme Pharma, Inc today announced that the Company will present recently announced topline data during oral presentations at two upcoming medical conferences.

May 23, 2024
·
9 min read
Biotech Beach

ChromaDex to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

ChromaDex Corp. today announced that its Chief Executive Officer, Rob Fried, and Chief Financial Officer, Brianna Gerber, will be participating in the Lytham Partners Spring 2024 Investor Conference, taking place virtually on Thursday, May 30, 2024.

May 23, 2024
·
2 min read
Business

NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.

NanoViricides, Inc. reports that it has engaged Aagami, Inc. for business development, specifically to seek licensing and partnering opportunities for our assets and platform technology.

May 23, 2024
·
9 min read
Biotech Bay

Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference

Vistagen today announced that it will present posters at the American Society of Clinical Psychopharmacology Conference in Miami Beach, Florida from May 28 to 31, 2024.

May 23, 2024
·
6 min read
Immorta Bio Inc, a Longevity Company, Announces a Significant Breakthrough in Treatment of Liver Failure

Immorta Bio Inc, a science-based Life Extension company has announced patent filing on successful treatment of the carbon tetrachloride model of liver failure using its PMSC-11 stem cell therapy.

May 23, 2024
·
3 min read
Pharm Country

Mitsubishi Tanabe Pharma America, Inc. (MTPA) Stands with the ALS Community

Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.

May 23, 2024
·
6 min read
Business

Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call

Moolec Science SA announced today that it will release its Business Update for the Third Quarter Fiscal Year 2024 on Thursday, May 30, 2024, before the market opens.

May 23, 2024
·
4 min read
Lone Star Bio

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

Autonomix Medical, Inc. today announced the successful completion of an animal study evaluating the ability of targeted nerve ablation to impact tumor metastases and growth.

May 23, 2024
·
4 min read
Drug Development

Melinta Therapeutics Announces Publication of the Outcomes by Candida Species from the ReSTORE Phase 3 trial and Recently Approved Rezafungin CLSI Breakpoints for Candida glabrata and Candida auris

Melinta Therapeutics Announces Publication of the Outcomes by Candida Species from the ReSTORE Phase 3 trial and Recently Approved Rezafungin CLSI Breakpoints for Candida glabrata and Candida auris.

May 23, 2024
·
4 min read
BioMidwest

Sarah Cannon Research Institute Expands into East Tennessee Through Collaboration with Tennessee Cancer Specialists

Sarah Cannon Research Institute announced a collaboration with Tennessee Cancer Specialists, an independent, private practice oncology group, based in Knoxville, Tenn.

May 23, 2024
·
3 min read